C3 glomerulopathy: exploring the role of the glomerular micro-environment in disease pathogenesis
C3 glomerulopathy (C3G) encompasses a group of severe renal diseases characterized by “dominant C3” deposition in the renal glomerulus. Patients typically present as nephritic nephrotics, with hematuria, hypertension, heavy proteinuria and edema. Within ten years of diagnosis, 50% of affected patien...
Main Author: | Xiao, Xue |
---|---|
Other Authors: | Smith, Richard J. H. |
Format: | Others |
Language: | English |
Published: |
University of Iowa
2017
|
Subjects: | |
Online Access: | https://ir.uiowa.edu/etd/6019 https://ir.uiowa.edu/cgi/viewcontent.cgi?article=7500&context=etd |
Similar Items
-
Unusual cause of glomerular deposition disease: Collagenofibrotic glomerulopathy
by: S Nimmagadda, et al.
Published: (2017-01-01) -
Complement Inhibitors in Clinical Trials for Glomerular Diseases
by: Peter F. Zipfel, et al.
Published: (2019-09-01) -
Complement Pathway Associated Glomerulopathies
by: Yasar Caliskan
Published: (2016-01-01) -
Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies
by: Markus A. Loeven, et al.
Published: (2021-08-01) -
Treating C3 glomerulopathy with eculizumab
by: Thomas Welte, et al.
Published: (2018-01-01)